Onnit Labs New Mood Supplementation in Healthy College Students

October 27, 2021 updated by: Ann Brown, University of Idaho

The Effect of Onnit New Mood Supplementation in Healthy Collegiate Men and Women

The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan. 5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.

Study Overview

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Idaho
      • Moscow, Idaho, United States, 83844
        • University of Idaho

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 24 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently enrolled collegiate men and women at the University of Idaho

Exclusion Criteria:

  • Currently taking mood or sleep enhancing supplementation/medication
  • Currently participating in counseling and/or therapy sessions
  • Previously diagnosed with a psychological disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: New Mood Supplementation
The New Mood herbal supplement includes lemon balm, 5-HPT, L-Tryptophan and valerian root.
Weeks 0-2 all participants consumed a placebo lead-in period and weeks 2-6 were intervention weeks. Throughout the 8 weeks (2 weeks placebo lead-in and 6 weeks intervention) participants were asked to consume 2 capsules (multi-ingredient supplement) upon waking in the morning and 2 capsules (multi-ingredient supplement) before bed.
Placebo Comparator: Placebo Supplementation
The placebo includes rice bran and maltodextrin.
Weeks 0-8 all participants consumed a placebo. Throughout the 8 weeks participants were asked to consume 2 capsules (placebo) upon waking in the morning and 2 capsules (placebo) before bed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cortisol awakening response (mg/dL) over 8 weeks
Time Frame: Change from baseline cortisol awakening response (mg/dL) at 8 weeks
Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks
Change from baseline cortisol awakening response (mg/dL) at 8 weeks
Change in resting heart rate (beats per minute) over 8 weeks
Time Frame: Change from baseline resting heart rate (beats per minute) response at 8 weeks
Manual radial pulse measurement of resting heart rate (beats per minute) at baseline and 8 weeks
Change from baseline resting heart rate (beats per minute) response at 8 weeks
Change in resting systolic and diastolic blood pressure (mm Hg) over 8 weeks
Time Frame: Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks
Digital sphygmomanometer measurement of resting systolic and diastolic blood pressure (mm Hg) at baseline and 8 weeks
Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks
Change in depression, anxiety and stress scores (0-34) over 8 weeks
Time Frame: Change from baseline DASS-21 score at 8 weeks
Depression, Anxiety and Stress Scale Questionnaire (DASS-21, 0-34) to assess depression, anxiety and stress scores from baseline to 8 weeks
Change from baseline DASS-21 score at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2018

Primary Completion (Actual)

May 3, 2019

Study Completion (Actual)

August 2, 2019

Study Registration Dates

First Submitted

December 10, 2020

First Submitted That Met QC Criteria

October 27, 2021

First Posted (Actual)

November 5, 2021

Study Record Updates

Last Update Posted (Actual)

November 5, 2021

Last Update Submitted That Met QC Criteria

October 27, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 18-138

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Wellness 1

Clinical Trials on Multi-Ingredient Herbal Supplement

Subscribe